share_log

Market-Moving News for December 18th

Market-Moving News for December 18th

12月18日的市場動向資訊
Benzinga ·  13:28

PLRZ: 282% | Polyrizon Secures GMP Manufacturing Partnership With Eurofins CDMO Amatsiaquitaine, Advancing Toward PL-14 Allergy Blocker Clinical Trial In 2025

PLRZ: 282% | Polyrizon與Eurofins CDMO Amatsiaquitaine達成GMP製造合作伙伴關係,朝着2025年的PL-14過敏阻斷臨床試驗邁進

CRVS: 24% | Corvus Pharmaceuticals shares are trading higher after the company announced it will report on December 18 interim data from its Phase 1 clinical trial evaluating Soquelitinib in patients with moderate to severe atopic dermatitis.

CRVS: 24% | Corvus Pharmaceuticals的股票在公司宣佈將在12月18日公佈其對中度至重度特應性皮炎患者進行的Soquelitinib一期臨床試驗的中期數據後上漲

OKLO: 10% | Oklo And Switch Partner To Deploy 12 GW Of Advanced Nuclear Power

OKLO: 10% | Oklo與交換機-雲計算合作,部署12GW的愛文思控股核電

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論